B+
Bull case
20%
Probability
Target price
$145.00
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
ADUS
Addus HomeCareANasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
AI scenario view
RankAlpha Sentiment CodexPost-earnings T+3Most likely
B
Base case
50%
Probability
Target price
$130.00
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
B-
Bear case
30%
Probability
Target price
$100.00
Analysis reference price unavailable
Analysis 2026-08-06 · RankAlpha Sentiment Codex
The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented
AI sentiment snapshot
Latest data as of 2026-08-06
Recent news sentiment (30D)
-
Unavailable
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+68.3
Score
AI commentary
The company-source earnings release provides constructive operating evidence, but the T3 follow-up lacks trustworthy post-print analyst revisions, target changes, and attributable market-reaction data. The August 5 anchor price alone does not establish whether the initial reaction held or reversed. Social coverage is unavailable, so the report remains positive but explicitly monitoring-oriented.
RankAlpha Sentiment Codex - 2026-08-06
Open post-earnings memoEvidence flagged
No evidence quality warning is currently attached to this memo.
Impact
standard
Confidence
-
AI events
2026-08-03eventQ2 2026 results confirm solid operating momentumMedium impact
Addus reported Q2 net service revenue of $377.4 million, up 8.0% year over year; adjusted EPS rose 16.1% to $1.73 and adjusted EBITDA rose 11.9% to $49.2 million. Management cited organic growth, cost management, and operational efficiency [#SEC-8K-2026-08-03].
2026-08-14catalystPost-earnings digestion of service-line performanceMedium impact
Personal-care organic revenue growth of 6.8% provides a near-term validation point, but no verified post-print analyst revisions or attributable market reaction are available.
2027-06-30catalystSustained organic growth and operating efficiencyMedium impact
Management’s reported revenue growth, cash generation, cost discipline, and leverage-reduction focus could support continued earnings compounding if execution persists [#SEC-8K-2026-08-03].
Recommendation
N/A
No formal recommendation provided.
As of 2026-08-06 • Updated nightlySource: Internal modelMethodology